Bio-engineered molecule shows promise for quick control of bleeding

Hematology researchers have developed a novel genetically engineered clotting factor that can control bleeding in animal models. If the factor proves effective in humans, it may provide a quick-acting countermeasure for surgery patients and others vulnerable to serious bleeding as a result of new blood-thinning drugs.